I agree that this site is using cookies. You can find further informations here.
X
Amin, Asim
230  results:
Search for persons X
?
1

Nivolumab with or without ipilimumab in patients with recur..:

Oaknin, Ana ; Moore, Kathleen ; Meyer, Tim...
The Lancet Oncology.  25 (2024)  5 - p. 588-602 , 2024
Link: https://doi.org/10.1016/..
 
?
2

Nivolumab monotherapy or combination with ipilimumab with o..:

Callahan, Margaret ; Amin, Asim ; Kaye, Frederic J...
Journal for ImmunoTherapy of Cancer.  12 (2024)  2 - p. e007883 , 2024
Link: https://doi.org/10.1136/..
 
?
3

Clinical outcomes of adjuvant nivolumab in resected stage I..:

Moser, Justin C. ; Bhatia, Shailender ; Amin, Asim...
Cancer Immunology, Immunotherapy.  73 (2024)  7 - p. , 2024
Link: https://doi.org/10.1007/..
 
?
4

Distinct Predictive Immunogenomic Profiles of Response to I..:

Eisner, Joel R. ; Beebe, Kirk D. ; Mayhew, Gregory M....
Cancer Research Communications.  2 (2022)  8 - p. 894-903 , 2022
Link: https://doi.org/10.1158/..
 
?
5

Long-Term Progression-Free Survival of Patients with Metast..:

Clark, Joseph I ; Curti, Brendan ; Davis, Elizabeth J...
Journal of Investigative Medicine.  69 (2021)  4 - p. 888-892 , 2021
Link: https://doi.org/10.1136/..
 
?
6

Venous thromboembolism incidence and risk factors in non-sm..:

Hill, Hailey ; Robinson, Myra ; Lu, Lauren...
Thrombosis Research.  208 (2021)  - p. 71-78 , 2021
Link: https://doi.org/10.1016/..
 
?
7

Nivolumab Monotherapy and Nivolumab Plus Ipilimumab in Recu..:

Ready, Neal E. ; Ott, Patrick A. ; Hellmann, Matthew D....
Journal of Thoracic Oncology.  15 (2020)  3 - p. 426-435 , 2020
Link: https://doi.org/10.1016/..
 
?
8

Survival outcomes and independent response assessment with ..:

Motzer, Robert J ; Escudier, Bernard ; McDermott, David F...
Journal for ImmunoTherapy of Cancer.  8 (2020)  2 - p. e000891 , 2020
Link: https://doi.org/10.1136/..
 
?
9

Intracranial antitumor activity with encorafenib plus binim..:

Holbrook, Kourtney ; Lutzky, Jose ; Davies, Michael A....
Cancer.  126 (2019)  3 - p. 523-530 , 2019
Link: https://doi.org/10.1002/..
 
?
10

Correction to: Safety and efficacy of nivolumab in combinat..:

Amin, Asim ; Plimack, Elizabeth R. ; Ernstoff, Marc S....
Journal for ImmunoTherapy of Cancer.  7 (2019)  1 - p. , 2019
Link: https://doi.org/10.1186/..
 
?
11

The Evolving Landscape of Immunotherapy-Based Combinations ..:

Amin, Asim ; Hammers, Hans
Frontiers in Immunology.  9 (2019)  - p. , 2019
Link: https://doi.org/10.3389/..
 
?
12

Spectrum and prevalence of BRCA1/2 germline mutations in Pa..:

Rashid, Muhammad Usman ; Muhammad, Noor ; Naeemi, Humaira...
Hereditary Cancer in Clinical Practice.  17 (2019)  1 - p. , 2019
Link: https://doi.org/10.1186/..
 
?
13

Safety and efficacy of nivolumab in combination with suniti..:

Amin, Asim ; Plimack, Elizabeth R ; Ernstoff, Marc S...
Journal for ImmunoTherapy of Cancer.  6 (2018)  1 - p. , 2018
Link: https://doi.org/10.1186/..
 
?
14

Impact of Sequencing Targeted Therapies With High-dose Inte..:

Clark, Joseph I. ; Wong, Michael K.K. ; Kaufman, Howard L....
Clinical Genitourinary Cancer.  15 (2017)  1 - p. 31-41.e4 , 2017
Link: https://doi.org/10.1016/..
 
?
15

MA09.05 Nivolumab Alone or with Ipilimumab in Recurrent Sma..:

Hellmann, Matthew ; Antonia, Scott ; Ponce, Santiago...
Journal of Thoracic Oncology.  12 (2017)  1 - p. S393-S394 , 2017
Link: https://doi.org/10.1016/..
 
1-15